NLM Logo

Etanercept MeSH Descriptor Data 2024


MeSH Heading
Etanercept
Tree Number(s)
D12.644.541.500.697.624
D12.776.124.486.485.538.500.624
D12.776.124.486.485.680.697.624
D12.776.124.790.651.538.500.624
D12.776.124.790.651.680.660.624
D12.776.377.715.548.538.500.624
D12.776.377.715.548.680.660.624
D12.776.543.750.705.852.760.232
Unique ID
D000068800
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068800
Scope Note
A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.
Entry Term(s)
Enbrel
Erelzi
Etanercept-szzs
Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein
TNF Receptor Type II-IgG Fusion Protein
TNFR-Fc Fusion Protein
TNR 001
TNR-001
TNT Receptor Fusion Protein
TNTR-Fc
Pharm Action
Anti-Inflammatory Agents, Non-Steroidal
Gastrointestinal Agents
Immunosuppressive Agents
Antirheumatic Agents
Related Numbers
185243-69-0
Public MeSH Note
2016; ETANERCEPT was indexed under IMMUNOGLOBULIN G and RECEPTORS, TUMOR NECROSIS FACTOR 1997-2015
History Note
2016 (1997)
Date Established
2016/01/01
Date of Entry
2015/07/09
Revision Date
2017/12/14
Etanercept Preferred
TNF Receptor Type II-IgG Fusion Protein Narrower
Enbrel Narrower
TNFR-Fc Fusion Protein Narrower
Erelzi Narrower
Etanercept-szzs Narrower
Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein Narrower
page delivered in 0.172s